2 high quality ASX 50 shares given buy ratings

Xero Limited (ASX:XRO) and this ASX 50 share have been given buy ratings. Here’s why they could be top options for investors today…

| More on:
asx investor daydreaming about US shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 50 index is home to 50 of the largest listed companies on the Australian share market.

While not all of the shares on the index are necessarily in the buy zone, two that could be are listed below. Here’s what you need to know about them:

CSL Limited (ASX: CSL)

The first ASX 50 share to look at is CSL. It is one of the world’s leading biotechnology companies with a portfolio of leading therapies and vaccines. This includes flu vaccines, immunoglobulins, and countless other plasma-based products.

However, the company isn’t settling for that. Each year CSL invests somewhere in the region of 11% of its sales back into research and development (R&D) activities. This ensures that the company’s R&D pipeline is filled to the brim with products that have the potential to generate millions and potentially even billions of dollars in sales each year.

In light of this and the improving outlook for plasma collections, a number of brokers are tipping CSL as a buy.

One of those is Citi. The broker currently has a buy rating and $310.00 price target on its shares.

Xero Limited (ASX: XRO)

Another ASX 50 share to consider buying is Xero. It is a leading cloud-based business and accounting software provider with a focus on small to medium sized businesses.

Over the last few years the Xero platform has evolved from a basic accounting solution into a full service small business solution. This has gone down well with small to medium sized businesses globally, leading to stellar subscription and revenue growth.

This continued in FY 2021, with Xero recently reporting an 18% increase in revenue to NZ$848.8 million and a 39% jump in EBITDA to NZ$191.2 million.

Looking ahead, Xero still has an enormous runway for growth. This is being underpinned by the ongoing shift to cloud solutions, its international expansion, and its burgeoning app ecosystem. The latter has been bolstered recently by a number of bolt on acquisitions such as Planday, Tickstar, and Waddle.

Goldman Sachs is very positive on its future. In light of this, it recently reaffirmed its buy rating and $153.00 price target on the company’s shares.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and Xero. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Blue Chip Shares

Expert says Telstra is a blue chip ASX 200 share to buy

Telstra could be an ASX 200 share to buy...

Read more »

Group of smiling coal miners in a coal mine
Blue Chip Shares

Clearly this is one of the cheapest ASX 200 stocks

Although the Whitehaven Coal share price has already soared 130% in 2022, it still looks incredibly cheap.

Read more »

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads news about the top ASX 200 shares today
Blue Chip Shares

2 blue chip ASX 200 shares analysts rate as buys

These blue chip shares could be buys in August...

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Broker names 3 ASX 200 shares to buy and hold

Here are three top shares for buy and hold investors...

Read more »

An attractive woman sits at her computer with her chin resting on her hand as she contemplates the WAM Alternative Assets listed investment company as a potential investment
Blue Chip Shares

Experts name 3 ASX 200 shares to buy now

Here are three ASX 200 shares named as buys...

Read more »

A happy team of businesspeople stand in a corporate office.
Broker Notes

Broker names 2 blue chip ASX shares to buy now

These blue chip ASX shares are highly rated by a top broker...

Read more »

man using laptop happy at rising share price
Blue Chip Shares

Why these blue chip ASX 200 shares are rated as buys by experts

These blue chip have been rated as buys...

Read more »

Two businesspeople walk together in an office, smiling as they enjoy a good business relationship.
Blue Chip Shares

Analysts rate these ASX 200 blue chip shares as buys

These blue chips have been named as buys...

Read more »